麻醉新进展 >文章正文
麻醉新进展 >文章正文
孙海燕 李平 何农 薛富善 Abstract Objective To investigate the effect of pre-emptive intrathecal (IT) administration of L-NAME, a non-selective nitric oxide synthase (NOS) inhibitor on calcitonin gene-related peptide (CGRP) expression in the dorsal horn of spinal cord in a rat model of neuropathic pain. Methods Ninety-six female adult SD rats weighing 220-310 g were randomly divided into four groups with 24 animals in each group: group A received IT 0.9% NaCl 15 min before sham operation; group B received IT 0.9% NaCl 15 min before right sciatic nerve ligation; group C received IT L-NAME 250 mg in 10μl 15 min before sham operation and group D received IT L-NAME 250μg in 10μl 15 min before sciatic nerve ligation. The animals were anesthetized with intraperitoneal pentobarbital 50 mg?kg-1. A PE-10 catheter was placed in subarachnoid space with the tip of the catheter reaching the lumbar enlargement region. The animals were allowed to recover for 3-4 days and only those waking normally were used in the study. Right sciatic nerve was exposed and four loose ligatures were placed on the sciatic nerve according to the method described by Bennet. In sham operation the sciatic nerve was exposed but not ligated. The animals were sacrificed on the 1 st, 4 th, 7 th and 14 th day after operation. The lumbar segment of spinal cord was immediately removed. The CGRP expression in the ligated-side dorsal horn was assessed with immunohistochemistry technique. Results In group B and D CGRP expression in the ligated side dorsal horn was significantly increased on the 4th, 7th and 14th day after operation as compared with that in group A. There was no significant difference in the CGRP expression in the ligated side dorsal horn between group A and C as well as between B and D. Conclusion Pre-emptive ITadministration of L-NAME cannot inhibit the increase in CGRP expression in dorsal horn induced by peripheral nerve injury, suggesting that the neuropathic pain mediated by NO is not related to the release of calcitonin gene-related peptide. 神经性疼痛是临床工作中的一种常见难治性疼痛。近年来认为,该类疼痛可能与伤害性感受信息经脊髓神经元多突触传递而诱发的“中枢敏化作用”有关[1],而一氧化氮(NO)作为体内一种重要的细胞信使分子,在调节脊髓神经元“可塑性”方面发挥着重要作用[2],但是NO在脊髓水平介导神经性疼痛的确切机制尚不清楚。本研究拟观察鞘内预注射非特异性一氧化氮合酶抑制剂NG-硝基-L-精氨酸-甲基酯(L-NAME)后神经性疼痛大鼠脊髓背角隆钙素基因相关肽(CGRP)的表达,探讨NO在脊髓水平调控伤害性感受信息传递的机制。 |
材料和方法<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /> 动物选择和分组 雌性成年SD大鼠(中国协和医科大学动物实验中心提供)96只,体重220~310g。随机分成4组,每组24只。A组:假手术组,鞘内注射0.9%氯化钠10μl,15min后实施假手术;B组:CCI组,鞘内注射0.9%氯化钠10μl,15min后结扎坐骨神经;C组:预处理后假手术组,鞘内注射L-NAME 10μl(250μg, Sigma公司,美国),15 min后实施假手术;D组:预处理后CCI组,鞘内注射L-NAME 10μl(250μg),15min后结扎坐骨神经。 结果 在低倍镜下,脊髓背角内CGRP免疫阳性纤维犹如一顶小帽扣在背角浅层,在高倍镜下可见较密集的末梢膨体,阳性纤维交织成网状。 |
讨论<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /> 在神经性疼痛形成的过程中,脊髓NMDA受体的活化发挥着关键作用[1]。研究显示,激动NMDA受体可引起Ca2+内流,从而激活细胞内钙敏感性一氧化氮合酶(NOS),促进NO生成[2]。通过增加细胞内cGMP的含量,NO可诱发神经元的“wind-up”效应,显著增强脊髓内的突触传递。 |